4/A//SEC Filing
Soffer Benny 4/A
Accession 0000899243-21-019993
CIK 0001824893other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 6:28 PM ET
Size
19.9 KB
Accession
0000899243-21-019993
Insider Transaction Report
Form 4/AAmended
Soffer Benny
Director
Transactions
- Disposition to Issuer
Class B Ordinary Shares
2020-10-08−718,750→ 2,875,000 total(indirect: See Footnote) - Award
Class B Ordinary Shares
2020-09-04$0.01/sh+3,593,750$25,156→ 3,593,750 total(indirect: See Footnote) - Disposition to Issuer
Class B Ordinary Shares
2020-11-10−575,000→ 2,300,000 total(indirect: See Footnote) - Sale
Class B Ordinary Shares
2020-11-18$0.01/sh−30,000$327→ 2,270,000 total(indirect: See Footnote) - Sale
Class B Ordinary Shares
2020-11-18$0.01/sh−30,000$327→ 2,240,000 total(indirect: See Footnote) - Sale
Class B Ordinary Shares
2020-11-18$0.01/sh−30,000$327→ 2,210,000 total(indirect: See Footnote) - Award
Class A Ordinary Shares
2020-11-23+410,000→ 410,000 total(indirect: See Footnote) - Award
Warrant
2020-11-23+136,667→ 136,667 total(indirect: See Footnote)Exercise: $11.50→ Class A Ordinary Shares (136,667 underlying)
Footnotes (7)
- [F1]Includes securities underlying the 410,000 private placement units of the Issuer purchased by Consonance Life Sciences, LLC (the "Sponsor") for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the Issuer's initial public offering. Each unit consists of one Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one Class A ordinary share at $11.50 per share.
- [F2]The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion over the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
- [F3]The warrants will become exercisable on the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering.
- [F4]The warrants will expire five years after the completion of the Issuer's initial business combination.
- [F5]Includes 136,667 warrants underlying the units referred to in footnote 1.
- [F6]This Form 4 amendment is being filed to correct the original Form 4 filed on November 25, 2020. The original Form 4 had the incorrect transaction code, and did not include reporting of all of the required transactions.
- [F7]The Sponsor contributed these shares back to the Issuer for no consideration.
Documents
Issuer
Consonance-HFW Acquisition Corp.
CIK 0001824893
Entity typeother
Related Parties
1- filerCIK 0001829318
Filing Metadata
- Form type
- 4/A
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 6:28 PM ET
- Size
- 19.9 KB